BLUEPRINT MEDICINES CORPORATION

Organization

Cambridge, MA, US

Ticker Symbols

NASDAQ:BPMC

PHARMACEUTICAL PREPARATIONS
Business Address
45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Mailing Address
45 SIDNEY STREET CAMBRIDGE MA 02139
State Location
MA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
EGFR inhibitors
- Patent number 12,172,983
- Issue date Dec 24, 2024
- Blueprint Medicines Corporation
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 12,060,354
- Issue date Aug 13, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAP4K1 inhibitors
- Patent number 12,042,495
- Issue date Jul 23, 2024
- Blueprint Medicines Corporation
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 11,999,744
- Issue date Jun 4, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2 inhibitors
- Patent number 11,970,498
- Issue date Apr 30, 2024
- Blueprint Medicines Corporation
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 11,964,980
- Issue date Apr 23, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2 inhibitors
- Patent number 11,932,648
- Issue date Mar 19, 2024
- Blueprint Medicines Corporation
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RET inhibitor for use in treating cancer having a RET alteration
- Patent number 11,872,192
- Issue date Jan 16, 2024
- Blueprint Medicines Corporation
- Erica Evans Raab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions useful for treating disorders related to KIT
- Patent number 11,827,642
- Issue date Nov 28, 2023
- Blueprint Medicines Corporation
- Brian L. Hodous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR inhibitors
- Patent number 11,718,602
- Issue date Aug 8, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 11,634,422
- Issue date Apr 25, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAP4K1 inhibitors
- Patent number 11,534,441
- Issue date Dec 27, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 11,279,688
- Issue date Mar 22, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RET inhibitor for use in treating cancer having a RET alteration
- Patent number 11,273,160
- Issue date Mar 15, 2022
- Blueprint Medicines Corporation
- Erica Evans Raab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PRKC fusions
- Patent number 11,261,497
- Issue date Mar 1, 2022
- Blueprint Medicines Corporation
- Nicolas Stransky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted pyrrolopyridines as inhibitors of activin receptor-like...
- Patent number 11,236,086
- Issue date Feb 1, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions useful for treating disorders related to...
- Patent number 11,059,827
- Issue date Jul 13, 2021
- Blueprint Medicines Corporation
- Steven Mark Wenglowsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions useful for treating disorders related to...
- Patent number 11,046,697
- Issue date Jun 29, 2021
- Blueprint Medicines Corporation
- Steven Mark Wenglowsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[1,2-b]pyridazines for treating disorders relate...
- Patent number 11,040,979
- Issue date Jun 22, 2021
- Blueprint Medicines Corporation
- Brian L. Hodous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PIK3C2G fusions
- Patent number 10,875,930
- Issue date Dec 29, 2020
- Blueprint Medicines Corporation
- Nicolas Stransky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 10,875,837
- Issue date Dec 29, 2020
- Blueprint Medicines Corporation
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating KIT- and PDGFRA-mediated dise...
- Patent number 10,829,493
- Issue date Nov 10, 2020
- Blueprint Medicines Corporation
- Thomas A. Dineen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions useful for treating disorders related to kit
- Patent number 10,807,985
- Issue date Oct 20, 2020
- Blueprint Medicines Corporation
- Kevin J. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,774,070
- Issue date Sep 15, 2020
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PIK3CA fusions
- Patent number 10,669,590
- Issue date Jun 2, 2020
- Blueprint Medicines Corporation
- Ethan G. Cerami
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 10,669,277
- Issue date Jun 2, 2020
- Blueprint Medicines Corporation
- Kevin J. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,584,114
- Issue date Mar 10, 2020
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NTRK2 fusions
- Patent number 10,407,509
- Issue date Sep 10, 2019
- Blueprint Medicines Corporation
- Nicolas Stransky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RAF1 fusions
- Patent number 10,378,063
- Issue date Aug 13, 2019
- Blueprint Medicines Corporation
- Nicolas Stransky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
TERT fusions
- Patent number 10,370,723
- Issue date Aug 6, 2019
- Blueprint Medicines Corporation
- Nicolas Stransky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240382483
- Publication date Nov 21, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING SYSTEMIC MASTOCYTOSIS AND GASTROINTESTINAL STR...
- Publication number 20240382493
- Publication date Nov 21, 2024
- BLUEPRINT MEDICINES CORPORATION
- Wendy Ankrom
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2 INHIBITORS
- Publication number 20240383902
- Publication date Nov 21, 2024
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240336630
- Publication date Oct 10, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
- Publication number 20240317757
- Publication date Sep 26, 2024
- BLUEPRINT MEDICINES CORPORATION
- Brian L. Hodous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240308981
- Publication date Sep 19, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARING EGFR INHIBITORS
- Publication number 20240300922
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Erika Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240299387
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR INHIBITORS
- Publication number 20240300946
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Thomas A. Dineen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT AND CRYSTAL FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIB...
- Publication number 20240293404
- Publication date Sep 5, 2024
- BLUEPRINT MEDICINES CORPORATION
- Erika Butler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS
- Publication number 20240287040
- Publication date Aug 29, 2024
- BLUEPRINT MEDICINES CORPORATION
- Philip D. Ramsden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
WILD TYPE KIT INHIBITORS
- Publication number 20240262826
- Publication date Aug 8, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT AND SOLID FORMS OF A KINASE INHIBITOR
- Publication number 20240254130
- Publication date Aug 1, 2024
- BLUEPRINT MEDICINES CORPORATION
- Erika Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZEPANONE-FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL...
- Publication number 20240217977
- Publication date Jul 4, 2024
- BLUEPRINT MEDICINES CORPORATION
- Gurulingappa Hallur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240199648
- Publication date Jun 20, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TRE...
- Publication number 20240166650
- Publication date May 23, 2024
- BLUEPRINT MEDICINES CORPORATION
- Gilles Caillot
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20240158398
- Publication date May 16, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1- METHYL-...
- Publication number 20240132510
- Publication date Apr 25, 2024
- BLUEPRINT MEDICINES CORPORATION
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PROTEIN KINASE A
- Publication number 20240132490
- Publication date Apr 25, 2024
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF EOSINOPHILIC DISORDERS WITH AVAPRITINIB
- Publication number 20240075041
- Publication date Mar 7, 2024
- BLUEPRINT MEDICINES CORPORATION
- Brenton Mar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PREPARING PRALSETINIB
- Publication number 20240059672
- Publication date Feb 22, 2024
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF
- Publication number 20240051945
- Publication date Feb 15, 2024
- BLUEPRINT MEDICINES CORPORATION
- Gurulingappa Hallur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISE...
- Publication number 20240010652
- Publication date Jan 11, 2024
- BLUEPRINT MEDICINES CORPORATION
- Thomas A. Dineen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF
- Publication number 20230416232
- Publication date Dec 28, 2023
- BLUEPRINT MEDICINES CORPORATION
- Gurulingappa Hallur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISE...
- Publication number 20230391780
- Publication date Dec 7, 2023
- BLUEPRINT MEDICINES CORPORATION
- Thomas A. Dineen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2 INHIBITORS
- Publication number 20230322791
- Publication date Oct 12, 2023
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF PRALSETINIB
- Publication number 20230295121
- Publication date Sep 21, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...
- Publication number 20230271971
- Publication date Aug 31, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRALSETINIB PHARMACEUTICAL COMPOSITIONS
- Publication number 20230203009
- Publication date Jun 29, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2 INHIBITORS
- Publication number 20230159535
- Publication date May 25, 2023
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
90546447 - GAVRETO
- Serial number 90546447
- Registration number 6613842
- Filing date Feb 25, 2021
- Blueprint Medicines Corporation
- 36 - Insurance
Information Trademark
90025145 - GAVSETY
- Serial number 90025145
- Filing date Jun 29, 2020
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90025140 - GAVRETO
- Serial number 90025140
- Filing date Jun 29, 2020
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88731372 - GAVSETO
- Serial number 88731372
- Filing date Dec 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88731368 - GAVSETY
- Serial number 88731368
- Filing date Dec 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88696714 - REFJETVI
- Serial number 88696714
- Filing date Nov 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88696686 - WURKETO
- Serial number 88696686
- Filing date Nov 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88675811 - AYVAKYT
- Serial number 88675811
- Filing date Oct 31, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88640502
- Serial number 88640502
- Filing date Oct 3, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88640785
- Serial number 88640785
- Registration number 7279558
- Filing date Oct 3, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88589364 - AYVAKIT
- Serial number 88589364
- Registration number 6790001
- Filing date Aug 22, 2019
- Blueprint Medicines Corporation
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88492527 - JORETVU
- Serial number 88492527
- Filing date Jun 27, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88492520 - GAVRETO
- Serial number 88492520
- Registration number 6309740
- Filing date Jun 27, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88478538 - JAVNIRYS
- Serial number 88478538
- Filing date Jun 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88478571 - JAYKITVA
- Serial number 88478571
- Filing date Jun 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88478516 - AYVAKITVA
- Serial number 88478516
- Filing date Jun 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88478478 - AYVAKIT
- Serial number 88478478
- Registration number 6563329
- Filing date Jun 18, 2019
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88444106 - ACCESS ASSISTANT
- Serial number 88444106
- Filing date May 23, 2019
- Blueprint Medicines Corporation
- 35 - Advertising
Information Trademark
88376992 - YOUR BLUEPRINT
- Serial number 88376992
- Registration number 6646801
- Filing date Apr 9, 2019
- Blueprint Medicines Corporation
- 35 - Advertising
Information Trademark
88208884 - M
- Serial number 88208884
- Registration number 6014600
- Filing date Nov 28, 2018
- Blueprint Medicines Corporation
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
88206503 - TAYKITVA
- Serial number 88206503
- Filing date Nov 27, 2018
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88156334 - ONTAYVA
- Serial number 88156334
- Filing date Oct 16, 2018
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88156329 - ZYRRAVI
- Serial number 88156329
- Filing date Oct 16, 2018
- Blueprint Medicines Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88066232 - MUTATION MATTERS
- Serial number 88066232
- Registration number 6014418
- Filing date Aug 6, 2018
- Blueprint Medicines Corporation
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments

BLUEPRINT MEDICINES CORPORATION

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

EGFR inhibitors

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

MAP4K1 inhibitors

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

CDK2 inhibitors

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

CDK2 inhibitors

RET inhibitor for use in treating cancer having a RET alteration

Compositions useful for treating disorders related to KIT

EGFR inhibitors

Inhibitors of activin receptor-like kinase

MAP4K1 inhibitors

Inhibitors of RET

RET inhibitor for use in treating cancer having a RET alteration

PRKC fusions

Substituted pyrrolopyridines as inhibitors of activin receptor-like...

Compounds and compositions useful for treating disorders related to...

Compounds and compositions useful for treating disorders related to...

Substituted pyrrolo[1,2-b]pyridazines for treating disorders relate...

PIK3C2G fusions

Inhibitors of the fibroblast growth factor receptor

Compositions and methods for treating KIT- and PDGFRA-mediated dise...

Compositions useful for treating disorders related to kit

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

PIK3CA fusions

Inhibitors of activin receptor-like kinase

Inhibitors of RET

NTRK2 fusions

RAF1 fusions

TERT fusions

Patents Applicationslast 30 patents

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

METHODS FOR TREATING SYSTEMIC MASTOCYTOSIS AND GASTROINTESTINAL STR...

CDK2 INHIBITORS

MAP4K1 INHIBITORS

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

PROCESS FOR PREPARING EGFR INHIBITORS

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

EGFR INHIBITORS

SALT AND CRYSTAL FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIB...

SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS

WILD TYPE KIT INHIBITORS

SALT AND SOLID FORMS OF A KINASE INHIBITOR

DIAZEPANONE-FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL...

MAP4K1 INHIBITORS

SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TRE...

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1- METHYL-...

INHIBITORS OF PROTEIN KINASE A

TREATMENT OF EOSINOPHILIC DISORDERS WITH AVAPRITINIB

METHOD OF PREPARING PRALSETINIB

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISE...

PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF

COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISE...

CDK2 INHIBITORS

SOLID FORMS OF PRALSETINIB

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...

PRALSETINIB PHARMACEUTICAL COMPOSITIONS

CDK2 INHIBITORS

Trademarklast 30 trademarks

90546447 - GAVRETO

90025145 - GAVSETY

90025140 - GAVRETO

88731372 - GAVSETO

88731368 - GAVSETY

88696714 - REFJETVI

88696686 - WURKETO

88675811 - AYVAKYT

88640502

88640785